# PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

> **NCT06486220** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Yun-fei Xia** · enrollment: 96 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Intestinal bacteria freeze-dried powder capsules

## Key facts

- **NCT ID:** NCT06486220
- **Lead sponsor:** Yun-fei Xia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486220, "PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06486220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*